Evommune’s Skin Disorder Study Falls Short

Read Also: Evommune Stock Cools Off After Big Rally On Successful Eczema Trial Evommune, Inc. (NYSE:EVMN) stock is trading lower on Monday after its investigational therapy EVO756 failed to meet the primary endpoint in a mid-stage study in patients with chronic...

Crude Oil Gains 2%; Comcast Shares Spike Higher

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.44% to 52,105.66 while the NASDAQ rose 1.33% to 25,634.54. The S&P 500 also rose, gaining, 0.79% to 7,412.29. Leading and Lagging...